[Form 3] The Ensign Group, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Uychiat Pison Marivic filed an Initial Statement of Beneficial Ownership for The Ensign Group, Inc. (ENSG) reporting direct ownership of 12,963 common shares and multiple employee stock options and restricted stock awards. Reported derivative holdings include options exercisable from 08/26/2020 through 11/06/2025 covering 17,559 shares in aggregate under various exercise prices, and unvested RSAs totaling 2,040 shares subject to five-year vesting schedules.

Positive

• Director alignment: Reporting person holds a combination of common shares, RSAs, and options which aligns interests with shareholders
• Transparent disclosure: Initial Form 3 provides clear detail on amounts, grant dates, vesting schedules, and exercise prices

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director filing showing equity ownership and multi-year vesting, aligning director incentives with shareholders.

The Form 3 documents initial disclosure of a director-level reporting person with a mix of vested common shares, vested and unvested restricted stock awards, and several employee stock options spanning 2020 to 2025 grant dates with expirations through 2034. The equity mix and staggered vesting indicate standard alignment incentives; there is no indication of unusual compensation terms or immediate dilution beyond normal option exercises.

Securities Analyst

TL;DR: Disclosure is informational and non-material to valuation by itself; it confirms insider alignment but not a material transaction.

The filing lists direct ownership of 12,963 shares and option rights to acquire an additional 17,559 shares under multiple grants with exercise prices ranging from $43.59 to $143. The presence of unvested RSAs (2,040 shares) and multi-year vesting schedules is typical for executive/director compensation and does not by itself signal a material change to share count or control.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Uychiat Pison Marivic

(Last) (First) (Middle)

29222 RANCHO VIEJO RD

STE 127

(Street)

SAN JUAN CAPISTRANO CA 92675

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/01/2025

3. Issuer Name and Ticker or Trading Symbol
ENSIGN GROUP, INC [ ENSG ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	12,963(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	08/26/2020(2)	08/26/2029	Common Stock	559	$43.59	D
Employee Stock Option (right to buy)	08/27/2021(3)	08/27/2030	Common Stock	3,000	$58.06	D
Employee Stock Option (right to buy)	02/19/2022(4)	02/19/2031	Common Stock	2,000	$83.64	D
Employee Stock Option (right to buy)	02/18/2023(5)	02/18/2032	Common Stock	2,500	$79.79	D
Employee Stock Option (right to buy)	05/18/2024(6)	05/18/2033	Common Stock	2,000	$90.85	D
Employee Stock Option (right to buy)	11/02/2024(7)	11/02/2033	Common Stock	5,000	$98.83	D
Employee Stock Option (right to buy)	11/06/2025(8)	11/06/2034	Common Stock	2,500	$143	D

Explanation of Responses:

1. Includes: 1) 160 unvested Restricted Stock Awards ("RSAs") from an award of 800 RSAs granted February 19, 2021; 2) 400 unvested RSAs from an award of 1,000 RSAs granted February 18, 2022; 3) 480 unvested RSAs from an award of 800 RSAs granted May 18, 2023; and 4) 1,000 unvested RSAs from an award of 1,000 RSAs granted November 6, 2024. RSA shares vest in five equal installments beginning on the first anniversary of the grant date.

2. These shares were granted August 26, 2019 and vested over 5 equal annual installments.

3. These shares were granted August 27, 2020 and vested over 5 equal annual installments.

4. These shares were granted February 19, 2021 and vest over 5 equal annual installments.

5. These shares were granted February 18, 2022 and vest over 5 equal annual installments.

6. These shares were granted May 18, 2023 and vest over 5 equal annual installments.

7. These shares were granted November 2, 2023 and vest over 5 equal annual installments.

8. These shares were granted November 6, 2024 and vest over 5 equal annual installments.

Remarks:

	/s/ Chad A. Keetch, as power of attorney	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Uychiat Pison Marivic report owning in ENSG on this Form 3?

She reports owning 12,963 common shares directly plus employee stock options and unvested restricted stock awards as detailed in the filing.

How many option shares and RSAs does the filing list for ENSG?

Options underlying 17,559 common shares are listed across seven grants and the filing discloses 2,040 unvested RSAs from multiple awards.

What are the exercise price ranges for the reported ENSG options?

Exercise prices range from $43.59 to $143 across the reported option grants.

Are the restricted stock awards vested immediately?

No; the RSA shares vest in five equal annual installments beginning on the first anniversary of each grant date, per the filing.

Does this Form 3 indicate a change in control or a material transaction for ENSG?

No; the Form 3 is an initial ownership disclosure and does not indicate a change in control or a material corporate transaction.